The primary objective is to compare ARIMIDEX (anastrozole) 1 mg once daily with Tamoxifen 20
mg once daily as adjuvant treatment in terms of: incidence of fatty liver diseases.
The second objectives are to compare ARIMIDEX (anastrozole) 1 mg once daily with Tamoxifen 20
mg once daily as adjuvant treatment in terms of: incidences of abnormal liver function test,
and time to treatment failure.